- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on t(11;14) Negative in Belgium
Total 169 results
-
Millennium Pharmaceuticals, Inc.Seagen Inc.CompletedMycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
University Medical Centre LjubljanaWithdrawnHelicobacter InfectionsIsrael, Belgium, Croatia, Germany, Slovenia
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
AZ Sint-Jan AVPaul Tulkens, Louvain drug research institute, belgium; Francoise Van Bambeke... and other collaboratorsCompletedGram-Negative Bacterial Infections | Renal Failure Chronic Requiring HemodialysisBelgium
-
University Hospital, GhentGlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Novartis Vaccines; University... and other collaboratorsCompletedPrevention of Infections With Bordetella PertussisBelgium
-
Aarhus University HospitalGCP-unit at Aarhus University Hospital, Aarhus, DenmarkCompletedLymphoma, T-Cell, PeripheralNorway, Belgium, Finland, Denmark, Austria, Czechia, Portugal, Germany, Netherlands, Poland, Sweden
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingSeptic Arthritis of the Native Hip | Failure of Initial DebridementBelgium
-
Biotronik AGCompletedde Novo Lesions in Native Coronary ArteriesNetherlands, Switzerland, Germany, Belgium
-
European Organisation for Research and Treatment...TerminatedLymphomaSpain, Finland, France, Germany, Switzerland, Belgium, Netherlands, Italy, Israel, Denmark, Hungary, United Kingdom, Austria
-
Queen Fabiola Children's University HospitalCentre National de Référence S.aureusUnknownCross Infection | Cystic Fibrosis | Pseudomonas AeruginosaBelgium
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
University of LiegeKU Leuven; Maastricht University Medical Center; University Hospital, Ghent; Queen... and other collaboratorsRecruitingGraft-versus-host Disease | Poor Graft Function | Low Donor T-cell ChimerismBelgium, Netherlands
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin Lymphoma | Anaplastic Large-cell LymphomaSpain, Belgium, Lithuania
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Pherecydes PharmaUnknownWound InfectionBelgium, France, Switzerland
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Institute of Tropical Medicine, BelgiumCompletedChlamydia Trachomatis Infection | Neisseria Gonorrhoeae InfectionBelgium
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsRecruitingTriple Negative Breast Cancer | HER2-negative Breast CancerSpain, France, Germany, Austria, Belgium, Ireland, Italy, Switzerland
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
TransgeneMerck Sharp & Dohme LLC; BioInvent International ABRecruitingMelanoma | Soft Tissue Sarcoma | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Merkel Cell CarcinomaFrance, Belgium
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Centre Hospitalier Universitaire Saint PierreCompletedPertussis | Pregnancy | HIV-1-infection | Immunization; InfectionBelgium
-
Bharat Biotech International LimitedRecruiting
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Janssen Research & Development, LLCCompletedPrecursor Cell Lymphoblastic Leukemia-LymphomaUnited States, United Kingdom, France, Sweden, Germany, Spain, Italy, Belgium, Israel, Netherlands
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Cliniques universitaires Saint-Luc- Université...CompletedChronic Hemodialysis Patients | Vascular Abord: Native Arterio-venous Fistula | Buttonhole CannulationBelgium
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
Novartis VaccinesCompletedPertussis | Whooping Cough | Tetanus | Diphtheria | LockjawBelgium
-
PfizerCompletedLyme BorreliosisUnited States, Germany, Belgium
-
4SC AGActive, not recruitingLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeAustria, Spain, Germany, United Kingdom, France, Belgium, Japan, Switzerland, Italy, Poland, Netherlands, Greece
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
PfizerValneva Austria GmbHCompletedLyme Borreliosis, Nervous SystemBelgium, United States
-
Bharat Biotech International LimitedActive, not recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers (Meningococcal Infection)India, South Africa
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLymphomaFrance, Spain, Italy, Belgium, Germany, Switzerland, Austria, United Kingdom, Netherlands, Sweden